Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development Overview
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEW
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEW
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety and quality.
COMPLIANCE OVERVIEW
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
Artificial intelligence is accelerating opportunities. Realizing the benefits for healthcare requires the right expertise. Together, we can solve the problems of today, and drive the breakthroughs of tomorrow.
LEARN MORE
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
IQVIA enables genomic research via global access to a network of genomic-clinical data, proprietary technologies that enable federated analytics, and therapeutic area & bioinformatics expertise to help you answer your most pressing research questions.
LEARN MOREOur mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORECareers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE
"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSA few questions to ponder… Do you feel like your trial will be more at risk if you cut out 100% SDV or CRAs visiting sites every 6 weeks? What if we don't catch missed adverse events or something more important? SAEs, Quality Issues? Are there higher risks with the risk-based approach? Well… what if the system you were using automates the data with traceability well enough that these potential issues are mitigated?
Gone are the days of subjects having to come into the office to complete all assessments – manually, more often than not.. Thank goodness as this eases subject and site burden and allows for increased enrollment opportunities in a trial. The ability to adapt as a result of a pandemic has accelerated clinical trials into a new paradigm. The MHRA has even come onboard stating, "The ICH GCP statement that, 'in general there is a need for on-site monitoring before, during and after the trial' is not recommended to be interpreted that on-site visits for assessment, initiation and on-going monitoring and closeout must always be performed."1Wow, does this open the door for a risk-based approach and for all of us to feel more comfortable?!
With a risk-based approached, the number of monitoring days onsite are reduced easing site, trial cost and sponsor burden. Gone are the days of queries being open for months on end. Sites are being held to contract agreements for data responsibilities - or at least they are getting notified of breaches more expeditiously than in non-risk based approach trials, leading to a happier project team. Well one less disheartening issue to deal with, at least!
Did you catch that key word earlier? Automation! The SaaS-based cloud system starts with Quality by Design at the Protocol Design step, however, can be implemented even later for trials already being conducted. Starting with libraries of therapeutically aligned configurable risks leveraged by IQVIA's over-12-years-of-risk-based experience, the system enables Integrated Monitoring across all of the roles that need to monitor data within the trial with insight as to what other roles are monitoring. Oversight is at the forefront of every trial.
Reviewing data at the Trial, Site and Subject levels provides the holistic data needed to identify the trends and issues triggering site contacts (queries, tele-visits, et al.), remote and/or onsite monitoring visits (and the MHRA condones it!). Issue identification enables dynamic, quality monitoring. It doesn't mean a site is not monitored, rather it's monitored for all of the data on the trial risk plan through the integrated monitoring strategies and based on the risks identified both predictive and actual. Issue prevention is paramount! Can you imagine being able to identify the majority of protocol deviations at the beginning of the trial and how prompt remediation can reduce ongoing deviations? The overall numbers of protocol deviations in a risk-based approach are significantly less- 50% less- as documented through IQVIA's proof points.
Data literacy of the data intelligence is system guided as well as supported by project advisory, if needed. It simplifies the reliance on self-taught and potentially inaccurate evaluations. User friendly and configurable analytics support trend and issue identification at all levels, whether reviewed through a medical team vs data management vs a CRA.
Use a SaaS based product configured to your staff, your way. It's an end to end solution which integrates with Customer systems, fits any trial size, and is your opportunity to run your own trial!
Combine data science, technology, and analytics driven by artificial intelligence to support new efficiencies and business insights -- without additional capital investment.
Ease the burden on your sites and make it easier and more appealing for patients to enroll and remain engaged.
Orchestrate outcomes for efficient clinical trials with an innovative CTMS and dynamic monitoring.
Orchestrate secure, compliant and real-time risk-based monitoring to improve overall study quality and increase efficiency while enhancing patient safety.
